← Back to Search

Dietary Supplement

Goode Health Beverage for High Blood Pressure

N/A
Recruiting
Led By Robert M Brothers, PhD
Research Sponsored by The University of Texas at Arlington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women who are between the ages of 18-55
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline & following 2 weeks of daily beverage consumption
Awards & highlights

Study Summary

This trial aims to find out how drinking a Good Health beverage every day affects both short-term and long-term measures of physical and brain health.

Who is the study for?
This trial is for individuals who want to improve their heart health and brain function. It's not clear what specific conditions or characteristics participants need to have, or what would disqualify someone from participating.Check my eligibility
What is being tested?
The study is testing the effects of a daily Goode Health Beverage on physical health markers like blood pressure and heart disease risk, as well as mental sharpness and cognitive abilities.See study design
What are the potential side effects?
Since the side effects are not provided, it's important for potential participants to ask about possible risks associated with the Goode Health Beverage during the consent process.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 55 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & following 2 weeks of daily beverage consumption
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & following 2 weeks of daily beverage consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Endothelial Function
Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)
Neurocognitive Function
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Goode Health BeverageExperimental Treatment1 Intervention
Goode Health Beverage that is high in natural ingredients that are high in Polyphenol 3 content and also have anti-inflammatory and antioxidant properties
Group II: Vanilla Base Blend BeveragePlacebo Group2 Interventions
The control beverage is similar but it does not contain the same amount of fiber, anti-inflammatory, and/or antioxidant properties (i.e. mainly smaller or no amounts of flax, ginger, cinnamon, turmeric, berberine bergamot, bilberry, black garlic, and green tea).

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor
43 Previous Clinical Trials
4,898 Total Patients Enrolled
Robert M Brothers, PhDPrincipal InvestigatorUniversity of Texas at Arlington
5 Previous Clinical Trials
199 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Which specific criteria must individuals meet in order to qualify as potential participants for this research study?

"Individuals aged between 18 and 55 years with a diagnosis of cardiovascular illness are sought after to participate in this research endeavor, aiming to recruit approximately 40 eligible candidates."

Answered by AI

Are individuals currently able to apply and participate in this ongoing clinical trial?

"Indeed, data from clinicaltrials.gov confirms the current recruitment status of this trial. Originally listed on October 1st, 2023 and last updated on January 29th, 2024, it is seeking to enroll a total of 40 participants across one center."

Answered by AI

Does this study include individuals who are above the age of 60?

"Individuals aged between 18 and 55 years are eligible for participation in this research study. Notably, there are a total of 112 trials tailored for those under 18 years old and a substantial number of 1564 trials targeting individuals over the age of 65."

Answered by AI

What is the current number of participants being recruited for this research study?

"Indeed, the details on clinicaltrials.gov affirm that this trial is currently enrolling participants. This research study was initially disclosed on October 1st, 2023, and most recently revised on January 29th, 2024. The goal is to recruit a total of 40 individuals from one designated site."

Answered by AI

Who else is applying?

What site did they apply to?
UT Arlington - Science and Engineering Innovation and Research Building
What portion of applicants met pre-screening criteria?
Met criteria

Why did patients apply to this trial?

Always looking to get healthier.
PatientReceived no prior treatments
~23 spots leftby Dec 2024